日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Strategies to target PD-1/PD-L1 in the tumor microenvironment

靶向肿瘤微环境中PD-1/PD-L1的策略

Kui, Yulan; Tong, Fan; Zhang, Ruiguang; Dong, Xiaorong; Wang, Jian

Roles of the phagocytosis checkpoint in radiotherapy

吞噬检查点在放射治疗中的作用

Kui, Yulan; Tong, Fan; Zhang, Ruiguang; Wang, Jian; Dong, Xiaorong

Potential utility of albumin-bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitors

基于白蛋白-胆红素和体重指数的逻辑回归模型在预测接受免疫检查点抑制剂治疗的非小细胞肺癌肝转移患者的生存结果方面的潜在应用价值

Song, Lianxi; Xu, Qinqin; Zhong, Ting; Guo, Wenhuan; Lin, Shaoding; Jiang, Wenjuan; Wang, Zhan; Deng, Li; Huang, Zhe; Qin, Haoyue; Yan, Huan; Zhang, Xing; Tong, Fan; Zhang, Ruiguang; Liu, Zhaoyi; Zhang, Lin; Dong, Xiaorong; Li, Ting; Fang, Chao; Chen, Xue; Deng, Jun; Wang, Jing; Yang, Nong; Zeng, Liang; Zhang, Yongchang

Role of radiotherapy in extensive-stage small cell lung cancer after durvalumab-based immunochemotherapy: A retrospective study

放射治疗在接受度伐利尤单抗免疫化疗后广泛期小细胞肺癌中的作用:一项回顾性研究

Chen, Lingjuan; Kong, Yi; Tong, Fan; Zhang, Ruiguang; Ding, Peng; Zhang, Sheng; Wang, Ye; Zhou, Rui; Pu, Xingxiang; Chen, Bolin; Liang, Fei; Tan, Qiaoyun; Xu, Yu; Wu, Lin; Dong, Xiaorong

Exploring the role of epigenetic regulation in cancer prognosis with epigenetic score

利用表观遗传评分探索表观遗传调控在癌症预后中的作用

Zhang, Ruiguang; Jin, Shimin; Xu, Qi; Dai, Rongxiao

Intrathecal pemetrexed for leptomeningeal metastasis from lung adenocarcinoma: a clinical efficacy and multiplex liquid proteomics exploration study

鞘内注射培美曲塞治疗肺腺癌软脑膜转移:一项临床疗效和多重液体蛋白质组学探索研究

Wang, Zhi; Ding, Peng; Zhou, Hongxia; Kuang, Bohua; Zhang, Ruiguang; Chen, Lingjuan; Zhang, Xing; Ge, Minghui; Liu, Yaqin; Tong, Fan; Dong, Xiaorong

Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLC.

基于淋巴细胞亚群的非侵入性生物标志物可预测 EGFR-TKI 预处理的 EGFR 突变型 NSCLC 的免疫化疗疗效

Song Lianxi, Zeng Liang, Xu Qinqin, Li Yizhi, Guo Wenhuan, Lin Shaoding, Jiang Wenjuan, Wang Zhan, Deng Li, Huang Zhe, Qin Haoyue, Yan Huan, Zhang Xing, Tong Fan, Zhang Ruiguang, Liu Zhaoyi, Zhang Lin, Yu Juan, Yang Xue, Xia Yang, Dong Xiaorong, Zhang Gao, Yang Nong, Zhang Yongchang

Radiotherapy combined with first-line anti-programmed cell death protein 1 (PD-1) immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer: A bicentric retrospective study

放疗联合一线抗程序性死亡蛋白1 (PD-1) 免疫疗法和化疗治疗晚期非小细胞肺癌患者:一项双中心回顾性研究

Huang, Yu; Ding, Peng; Zhang, Ruiguang; Zhang, Yongchang; Tong, Fan; Cheng, Shishi; Peng, Ling; Jie, Xiaohua; Wang, Jian; Liu, Pian; Zhang, Sheng; Wu, Gang; Yang, Nong; Dong, Xiaorong

Retraction Notice to: lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer

撤稿声明:lncRNA UCA1作为ceRNA通过海绵吸附miR-143靶向FOSL2,促进非小细胞肺癌患者对吉非替尼的耐药性

Chen, Xiliu; Wang, Zhongliang; Tong, Fan; Dong, Xiaorong; Wu, Gang; Zhang, Ruiguang

Analysis of Baseline Molecular Factors Associated With the Risk of Central Nervous System Progression Among Alectinib-Treated Patients With ALK-Positive NSCLC

对接受阿来替尼治疗的ALK阳性非小细胞肺癌患者中枢神经系统进展风险相关的基线分子因素进行分析

Song, Lianxi; Yan, Huan; Xu, Qinqin; Zhou, Chunhua; Liang, Juan; Lin, Shaoding; Zhang, Ruiguang; Yu, Juan; Xia, Yang; Yang, Nong; Zeng, Liang; Zhang, Yongchang